Does Trastuzumab Cause Cardiotoxicity in the Treatment of Patients with Breast Cancer? Reply

被引：0
|
作者：
Tan, Timothy C. [1 ]
Scherrer-Crosbie, Marielle
机构：
[1] Massachusetts Gen Hosp, Cardiac Ultrasound Lab, Boston, MA 02114 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY | 2015年 / 28卷 / 09期
关键词：
EJECTION FRACTION; CARDIAC TOXICITY;
D O I：
10.1016/j.echo.2015.07.024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1129 / 1130
页数：3
相关论文
共 50 条
  • [41] A Prospective Cohort Study on Cardiotoxicity of Adjuvant Trastuzumab Therapy in Breast Cancer Patients
    Matos, Erika
    Jug, Borut
    Blagus, Rok
    Zakotnik, Branko
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2016, 107 (01) : 40 - 47
  • [42] THE IMPACT OF CARDIOTOXICITY AND TRASTUZUMAB INTERRUPTION ON BREAST CANCER OUTCOMES
    Copeland-Halperin, Robert
    Al-Sadawi, Mohammed
    Patil, Sujata
    Yadav, Nandini
    Liu, Jennifer E.
    Dang, Chau
    Steingart, Richard
    Yu, Anthony F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 741 - 741
  • [43] Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
    Marinko, Tanja
    Dolenc, Jure
    Bilban-Jakopin, Cvetka
    RADIOLOGY AND ONCOLOGY, 2014, 48 (02) : 105 - 112
  • [44] Anthracycline and trastuzumab-induced cardiotoxicity in breast cancer
    Nicolazzi, M. A.
    Carnicelli, A.
    Fuorlo, M.
    Scaldaferri, A.
    Masetti, R.
    Landolfi, R.
    Favuzzi, A. M. R.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (07) : 2175 - 2185
  • [45] Trastuzumab cardiotoxicity in early-stage breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2016, 17 (06): : E226 - E226
  • [46] Prolonged electromechanical delay as an early predictor of trastuzumab-induced cardiotoxicity in patients undergoing treatment for breast cancer
    Choe, Jeong Cheon
    Choi, Jung Hyun
    Choi, Jong Hyun
    Ahn, Jinhee
    Park, Jin Sup
    Lee, Hye Won
    Oh, Jun-Hyok
    Lee, Han Cheol
    Cha, Kwang Soo
    Hong, Taek Jong
    CLINICAL CARDIOLOGY, 2018, 41 (10) : 1308 - 1314
  • [47] Cardiotoxicity in HER-2 positive patients, with advanced breast cancer, receiving several years of treatment with trastuzumab
    Larsen, A. K.
    Jensen, A. B.
    Langkjer, S. T.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S183 - S184
  • [48] Global Longitudinal Strain Accuracy for Cardiotoxicity Prediction in a Cohort of Breast Cancer Patients During Anthracycline and/or Trastuzumab Treatment
    Gripp, Eliza de Almeida
    de Oliveira, Gabriela Escudini
    Feijo, Luiz Augusto
    Garcia, Marcelo Iorio
    Xavier, Sergio Salles
    de Sousa, Andrea Silvestre
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2018, 110 (02) : 140 - 150
  • [49] Trastuzumab Deruxtecan for Breast Cancer REPLY
    Cortes, Javier
    Im, Seock-Ah
    Cathcart, Jillian
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (24): : 2347 - 2347
  • [50] Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
    Guglin, Maya
    Krischer, Jeffrey
    Tamura, Roy
    Fink, Angelina
    Bello-Matricaria, Lauren
    McCaskill-Stevens, Worta
    Munster, Pamela N.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (22) : 2859 - 2868
12345